Published: Feb, 2018

Players in the fragmented global optometry market, many in all, are pulling out every stop to retain their market shares and make headway. They are mostly seen banking upon improved therapies and treatments to outsmart their rivals and progress. The bigger companies operating in the market have attained an influential position by dint of their wide-ranging product portfolio and extensive geographical outreach.

Transparency Market Research classifies Novartis AG, CooperVision, Pfizer, Inc., Essilor, Valeant Pharmaceuticals International, Inc., Johnson & Johnson Vision Care, Inc., and Allergan as some of the prominent players in the global market for optometry.


Our recent report on the global market for optometry shows that it will rise at a tepid 4.1% CAGR between 2017 and 2025. At this pace, the market which was valued at US$55.974 bn in 2016, will likely pull in a value of US$79.871 bn by end of 2025.

The two main types of products in the optometry market are therapeutics and vision care equipment. The therapeutics segment can be divided again into anti-inflammatory drugs, anti-infective drugs, anti-fungal drugs, and anti-allergy drugs. And savvy players are mostly seen betting on the anti-inflammatory drugs segment since they are pulling in maximum sales and revenue at present. In 2016, the segment contributed about 32.5% in the overall revenue in the market.

Geographically, North America is the region which could well spell opportunity for keen manufacturers for the region accounted for a leading share of 36.5% in the global market for optometry in 2016. The market has been buoyed so far by the developed economies and their solid healthcare infrastructure. In addition, strong awareness among people about the different treatments for eye diseases is also bolstering the market in the region.

Global Optometry MarketLarge Pool of Elderly Susceptible to Visual Problems Mainly Fuelling Demand

Primarily serving to catalyze growth in the global market for optometry is the rising elderly population who are highly susceptible to different visual problems resulting from different chronic health conditions, namely diabetes. Apart from that, rising instances of age-related macular degeneration, glaucoma, diabetic retinopathy, and cataract is also pushing up demand in the optometry market. Adds the lead analyst of the TMR report, “In the U.S. alone, according to the American Association of Ophthalmology, around 20.5 million patients suffer from cataract and 7.6 million suffer from diabetic retinopathy. Hence, the growing instance of eye diseases and refractive errors has upped the need for examination of the eye as well as eye care.”

Technological Progress Fillips Market

Thanks to constant progress on the technological front, we can expect to be cured of many visual problems. In fact, about 80% of all cases of visual impairment can be thwarted or cured. This, no doubt, is positive news for the optometry market. Besides, soaring popularity of contact lenses or specs has also led had a positive bearing on the sales in the optometry market. With increasing disposable incomes, people are more eager to change the models of their spectacles in keeping with the latest fashion, which will definitely help players boost sales.

This review is based on the findings of a TMR report, titled, “Optometry Market (Type - Therapeutics (Anti-inflammatory Drugs (Steroids and NSAIDS), Anti-fungal Drugs, Anti-infective Drugs, and Anti-allergic Drugs) and Vision Care Equipment (Eye Glasses and Contact Lenses (Soft Contact Lenses, Rigid Gas Permeable Lenses, and Extended Wear Contact Lenses); Distribution Channel - Hospital Pharmacies, Optometry Clinics, Online and Retail Stores, and Optical Centers) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017–2025

Key Takeaways:

  • Companies leverage better treatments and therapies to stay ahead of the curve in the global optometry market
  • Burgeoning elderly population and advancements in technology drive demand in market

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453